Wang Maud, Farouki Yousra, Hulscher Franny, Mine Benjamin, Bonnet Thomas, Elens Stephanie, Vazquez Suarez Juan, Jodaitis Lise, Ligot Noémie, Naeije Gilles, Lubicz Boris, Guenego Adrien
Department of Interventional Neuroradiology, Erasme University Hospital, Brussels, Belgium.
Department of Radiology, University Hospitals Leuven, Leuven, Belgium.
Front Neurol. 2022 Mar 7;13:809066. doi: 10.3389/fneur.2022.809066. eCollection 2022.
Good clinical outcome predictors have been established in mechanical thrombectomy (MT) for acute ischemic stroke (AIS) caused by large vessel occlusion (LVO). An early neurological improvement (ENI), defined as a reduction of ≥8 on the National Institutes of Health Stroke Scale (NIHSS), compared with the baseline score or an NIHSS of 0 or 1 at 24 h after MT, is a strong predictor of favorable outcome. We aimed to study the impact of ENI after MT for distal medium vessel occlusions (DMVO).
We retrospectively analyzed the data of consecutive patients who underwent MT for a primary DMVO in one large academic center. We compared clinical outcomes between patients with DMVO stratified by ENI. Multivariate analyses were performed to determine the impact of ENI on good 90-day outcome (modified Rankin scale of 0-2) and identify factors contributing to ENI.
Between January 2018 and January 2021, 61 patients underwent an MT for an AIS with a primary DMVO. An ENI was seen in 24 (39%) patients (ENI+). Outcomes were significantly better in ENI+ patients, with 83% achieving a good outcome at 3 months vs. 43% for patients without ENI (ENI-; = 0.019). ENI was an independent predictive factor of good clinical outcome even after adjusting for potential confounding factors [odds ratio 12.49 (1.49-105.01), = 0.020]. The use of intravenous tissue plasminogen activator [IVtPA; Odds-ratio 6.59 (1.82-23.89), = 0.004] was a positive predictor of ENI.
ENI at day 1 following MT for DMVO stroke is a strong independent predictor of good to excellent 3-month clinical outcome.
在因大血管闭塞(LVO)导致的急性缺血性卒中(AIS)的机械取栓术(MT)中,已经确立了良好的临床结局预测指标。早期神经功能改善(ENI),定义为与基线评分相比,美国国立卫生研究院卒中量表(NIHSS)评分降低≥8分,或在MT后24小时NIHSS评分为0或1分,是良好结局的有力预测指标。我们旨在研究MT治疗远端中等血管闭塞(DMVO)后ENI的影响。
我们回顾性分析了在一个大型学术中心接受原发性DMVO的MT治疗的连续患者的数据。我们比较了根据ENI分层的DMVO患者的临床结局。进行多变量分析以确定ENI对90天良好结局(改良Rankin量表评分为0-2)的影响,并确定促成ENI的因素。
2018年1月至2021年1月期间,61例患者因原发性DMVO接受了AIS的MT治疗。24例(39%)患者出现ENI(ENI+)。ENI+患者的结局明显更好,3个月时83%的患者获得良好结局,而无ENI的患者(ENI-)为43%(P = 0.019)。即使在调整潜在混杂因素后,ENI仍是良好临床结局的独立预测因素[优势比12.49(1.49-105.01),P = 0.020]。静脉使用组织型纤溶酶原激活剂[IVtPA;优势比6.59(1.82-23.89),P = 0.004]是ENI的阳性预测指标。
DMVO卒中MT术后第1天的ENI是3个月时良好至优异临床结局的有力独立预测指标。